< 1 minute read
Aug. 15, 2021
LNP023: A selective factor B serine protease inhibitor
LNP023
selective factor B serine protease inhibitor orally available, retinal barrier penetrant J. Med. Chem., Feb. 19, 2020 Novartis (NIBR), Cambridge, MA
selective factor B serine protease inhibitor orally available, retinal barrier penetrant J. Med. Chem., Feb. 19, 2020 Novartis (NIBR), Cambridge, MA